Nymox Pharmaceutical Corp (NYMX.O)

+ 收藏

财务摘要(报告期)(Nymox Pharmaceutical Corp)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年年报2024年三季报2023年年报2023年三季报2023年中报2023年一季报
每股指标:
 每股收益EPS基本(元) 会员可见会员可见会员可见会员可见-0.03-0.02
 每股净资产(元) 会员可见会员可见会员可见会员可见-0.03-0.02
 每股经营现金净流量(元) 会员可见会员可见会员可见会员可见-0.02-0.01
 每股现金流量净额(元) --会员可见会员可见-0.01-0.01
盈利能力:
 净资产收益率平均(%) 会员可见会员可见会员可见会员可见148.68121.61
 总资产净利率(%) 会员可见会员可见会员可见会员可见-263.40-126.09
 投入资本回报率ROIC(%) 会员可见会员可见会员可见会员可见-1,012.98-348.06
收益质量:
 营业利润/利润总额(%) 会员可见会员可见会员可见会员可见99.4499.86
资本结构:
 资产负债率(%) 会员可见会员可见会员可见会员可见1,161.62412.87
 权益乘数 会员可见会员可见会员可见会员可见-0.09-0.32
 产权比率 会员可见会员可见会员可见会员可见-1.09-1.32
 流动资产/总资产(%) 会员可见会员可见会员可见会员可见78.9780.17
 非流动资产/总资产(%) 会员可见会员可见会员可见会员可见21.0319.83
 流动负债/负债合计(%) 会员可见会员可见会员可见会员可见100.00100.00
 归属母公司股东的权益/投入资本(%) 会员可见会员可见会员可见会员可见-1,061.62-312.87
偿债能力:
 流动比率 会员可见会员可见会员可见会员可见0.070.19
 速动比率 会员可见会员可见会员可见会员可见0.070.19
 货币资金/流动负债(%) 会员可见-会员可见---
 营业利润/流动负债(%) 会员可见会员可见会员可见会员可见-78.88-58.34
 经营活动产生的现金流量净额/流动负债(%) 会员可见会员可见会员可见会员可见-60.26-41.62
 归属母公司股东的权益/负债合计(%) 会员可见会员可见会员可见会员可见-91.39-75.78
 经营活动产生的现金流量净额/负债合计(%) 会员可见会员可见会员可见会员可见-60.26-41.62
 营业利润/负债合计(%) 会员可见会员可见会员可见会员可见-78.88-58.34
成长能力:
 总资产同比增长率(%) 会员可见会员可见会员可见会员可见-93.94-53.55
 每股净资产同比增长率(%) 会员可见会员可见会员可见会员可见-228.90-29.09
 总负债同比增长率(%) 会员可见会员可见会员可见会员可见40.41-9.67
 基本每股收益同比增长率(%) 会员可见-会员可见会员可见25.0066.67
 归属母公司股东的权益同比增长率(%) 会员可见会员可见会员可见会员可见-228.90-29.42
 营业利润同比增长率(%) 会员可见会员可见会员可见会员可见63.7472.70
 营业收入同比增长率(%) -会员可见----
 股东权益合计同比增长率(%) 会员可见会员可见会员可见会员可见-228.90-29.42
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) 会员可见会员可见会员可见会员可见-3,938,000.00-321,000.00
 利润总额TTM(元) 会员可见会员可见会员可见会员可见-5,327,000.00-2,877,000.00
 投入资本(元) 会员可见会员可见会员可见会员可见271,000.00575,000.00
 经营活动产生的现金流量净额TTM(元) 会员可见会员可见会员可见会员可见-4,452,000.00-1,986,000.00
 归属母公司净利润TTM(元) 会员可见会员可见会员可见会员可见-5,327,000.00-2,877,000.00

前瞻产业研究院